Tower Resources PLC’s (LON:TRP) 50% owned Algoa-Gamtoos exploration area has been boosted by a significant new gas condensate discovery at the neighbouring Brulpadda exploration project, offshore South Africa.
Katoro Gold PLC (LON:KAT), the Tanzania focused gold exploration and development company, has settled some bills through the issue of shares and granted options to the board and management of the company.
Healthcare investment company Arix Bioscience Plc (LON:ARIX) said a fourth portfolio company is listing on the stock market – providing an uplift to the valuation of its shareholding. Harpoon Therapeutics, which is developing T-cell immunotherapies for cancer, is raising £58.4mln from the NASDAQ float.
IQ-AI Ltd (LON:IQAI) has made the first sale of its Imaging Biometrics (IB) software to South Korea, while its StoneChecker software has received a Medical Information Bulletin from the UK's National Institute for Health and Care Excellence (NICE). The company said its distributor, Korea Computer ISG has sold a suite of IB neuroradiology software to Haeundae Paik Hospital in Busan.
Nektan PLC (LON:NKTN) revealed that it has received more support for the placing and subscription it launched in December than previously announced, with demand currently at £2.2mln, significantly above the initial minimum of £1.5mln.
Security specialist Westminster Group PLC (LON:WSG) is to raise £500,000 to bolster its working capital position and help with preparation for a number of projects outlined in January’s business update. In that statement, Westminster said trading in 2019 had started strongly.
Vast Resources PLC (LON:VAST) has appointed Paul Fletcher as its new chief financial officer with immediate effect.
ECR Minerals PLC (LON:ECR), the precious metals exploration and development company, announced that its drill programme at the Creswick gold project in the state of Victoria, Australia, has commenced and the first four holes have been successfully completed.
Summit Therapeutics PLC (LON:SUMM) ((NASDAQ:SMMT), a leader in new mechanism antibiotic innovation, announced that its chief executive officer, Glyn Edwards will present at the BIO CEO & Investor Conference on 11 February 2019 at 10:00am EST in New York City. It said a live webcast of the presentation will be available in the Investors section of the company's website.
SigmaRoc PLC (LON:SRC) the AIM-quoted buy-and-build construction materials group, late yesterday announced the appointment, with immediate effect, of Liberum Capital as its joint broker, alongside its existing broker, Berenberg.